CuroTis

Maastricht, Netherlands · Founded 2016 · Privately Held (backing)

Developer of a tissue engineering technology designed for novel therapeutic options for vascular surgery. CuroTis is based in Maastricht, Netherlands and was founded in 2016. Its last reported valuation was $15.7 million in Jan 2025. It has raised $4.4 million.

Last reported valuation
$15.7M
Oct 2026
Priced at
—
Total raised
$4.4M
Last round
—

Who backs CuroTis?

7 investors
InvestorType
High-Tech GründerfondsVenture capital
Rijksdienst voor Ondernemend NederlandOther
Limburg Development and Investment CompanyOther
Brightlands Venture Partners—
GIMIC Ventures—
Limburg Business Development Fund—
Maastricht University—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CuroTis investors

7 investors are on record for CuroTis, including High-Tech Gründerfonds, Rijksdienst voor Ondernemend Nederland, Limburg Development and Investment Company and Brightlands Venture Partners.

Free account
More of CuroTis with a free account
  • ·Watch CuroTis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like CuroTis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View